BNP/PUT/NOVARTIS N/100/0.1/20.12.24 Share Price

Warrant

DE000PC25CD6

Real-time Boerse Frankfurt Warrants 15:21:21 26/06/2024 BST
0.69 EUR 0.00% Intraday chart for BNP/PUT/NOVARTIS N/100/0.1/20.12.24
Current month-25.00%
1 month-29.59%
Date Price Change
26/06/24 0.69 0.00%
25/06/24 0.69 +1.47%
24/06/24 0.68 -12.82%
21/06/24 0.78 -8.24%
20/06/24 0.85 +1.19%

Real-time Boerse Frankfurt Warrants

Last update June 26, 2024 at 03:21 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC25CD
ISINDE000PC25CD6
Date issued 10/01/2024
Strike 100 CHF
Maturity 20/12/2024 (177 Days)
Parity 10 : 1
Emission price 1.29
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.67
Lowest since issue 0.63
Delta-0.6x
Omega 8.562
Premium2.54x
Gearing14.38x
Moneyness 1.044
Difference Strike 4.065 CHF
Difference Strike %+4.07%
Spread 0.01
Spread %1.43%
Theoretical value 0.6950
Implied Volatility 17.41 %
Total Loss Probability 36.14 %
Intrinsic value 0.4354
Present value 0.2596
Break even 93.34 €
Theta-0.01x
Vega0.03x
Rho-0.03x

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
107.2 USD
Average target price
110.3 USD
Spread / Average Target
+2.88%
Consensus